(To see other currencies, click on price)
MORE ABOUT THIS BOOK
Main description:
Over the past few decades, cardiovascular disease and diabetes have emerged as major public health problems, both as distinct clinical entities and as comorbid conditions. As a result, the fields of vascular biology and endocrinology are working more closely now than ever before. With chapters by renowned experts, Cardiovascular Endocrinology: Shared Pathways and Clinical Crossroads emphasizes the considerable physiological interrelationships and clinical correlations between the specialties of cardiovascular medicine and endocrinology.
Offering a wealth of information, Cardiovascular Endocrinology: Shared Pathways and Clinical Crossroads provides a range of insights, including a novel view of the hormonal regulation of the vascular system and the disruption of the nitric oxide signaling system. It also addresses the role of fatty acids and cytokines in the development of this problem. Importantly, this unique title also provides a state-of-the-art update on the importance of other hormones such as thyroid hormone and steroids, as well as the pathophysiology of cardiovascular disease and controversies surrounding the use of hormone replacement therapy.
In all, Cardiovascular Endocrinology: Shared Pathways and Clinical Crossroads is a first-of-its-kind title that discusses and summarizes important clinical topics in cardiology and endocrinology. It offers clinicians and researchers an important resource for navigating the increasingly interrelated pathways of cardiovascular and endocrinologic disorders. The authors discuss a range of important issues from epidemiology to bench research to translation of this research to clinical practice.
Contents:
Hormonal Regulation of the Vascular System by Hsueh, LeRoith, Fonseca Chapter 1. Epidemiology of Cardiovascular Disease in Diabetes by Meigs Chapter 2. Pathophysiology - From Oxidative Stress to Endothelial Dysfunction and Inflammation by Jialal Chapter 3. Disruption of the Nitric Oxide Signalling System in Diabetes by McNamara Chapter 4. The Metabolic Syndrome - Clinical Entity or Misnomer by Deedwania Chapter 5. Fatty Acids and Adipokines by Boden Chapter 6. Insulin - An Anti-atherosclerotic Agent by Dandona Chapter 7. Insulin Sensitizers and Cardiovascular Disease by Fonseca Chapter 8. Screening for CVD in Symptomatic and Asymptomatic Patients with Diabetes by Raggi Chapter 9. New Observations in the Epidemiology of Hypertension - role of Hormones by Muntner and He Chapter 10. Aldosterone and Cardiovascular Disease by Weber Chapter 11. The Renin-Angiotensin System by Sowers Chapter 12. Optimal Treatment of Hypertension to Prevent Cardiovascular Events by Black Chapter 13. Microalbuminuria and Chronic Kidney Disease as Cardiovascular Risk Factors by Bakris Chapter 14. Impact of Obesity on Cardiovascular Disease by Dagogo, Jack/Kern Chapter 15. Adiponectin Vascular Protective Agent by Bajaj Chapter 16. Postmenopausal Hormone Replacement Therapy - Controversies and Solutions Chapter 17. Testosterone and Cardiovascular Disease by Seftel, Shabshig Chapter 18. Sexual Dysfunction and Cardiovascular Disease - Links and Solutions by Matfin Chapter 19. Natriuretic Peptides by Pandey, Sowers Chapter 20. Calcium Metabolism and Cardiovascular Disease by Zaidi Chapter 21. Adrenal Steroids in the Vasculature Chapter 22. DHEA - Snake Oil or Vascular Protector by Svec.
PRODUCT DETAILS
Publisher: Springer (Humana Press Inc.)
Publication date: October, 2008
Pages: 268
Weight: 870g
Availability: Available
Subcategories: Cardiovascular Medicine, Diseases and Disorders, Endocrinology
From the same series
